Other adverse reaction research
- PDF / 152,056 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 2 Downloads / 193 Views
1
Other adverse reaction research Below is a list of other recently published drug safety-related scientific literature.
•
Ageno W, et al. Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study. Thrombosis and Haemostasis : 17 Nov 2020. Available from: URL: http://dx.doi.org/10.1055/s-0040-1720975
•
Agusti A, et al. Withdrawal of hospital outpatient treatments in severe diseases due to unacceptable toxicity: A retrospective study from the Register of Patients and Treatments. British Journal of Clinical Pharmacology : 20 Nov 2020. Available from: URL: http://dx.doi.org/10.1111/bcp.14665
•
Al-Qurain AA, et al. Opioid prescribing and risk of drug-opioid interactions in older discharged patients with polypharmacy in Australia. International Journal of Clinical Pharmacy : 18 Nov 2020. Available from: URL: http:// dx.doi.org/10.1007/s11096-020-01191-1
•
Dhochak N, et al. Hypersensitivity Myocarditis Due to Antitubercular Drugs in Children. Pediatric Infectious Disease Journal : 3 Aug 2020. Available from: URL: http://dx.doi.org/10.1097/INF.0000000000002844
•
Freitas R, et al. Safety and Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs in Older Patients with Rheumatoid Arthritis: A Prospective Cohort Study. Drugs and Aging : 18 Nov 2020. Available from: URL: http:// dx.doi.org/10.1007/s40266-020-00801-x
•
Hellstrom L, et al. Prospective observational study of medication reviews in internal medicine wards: evaluation of drug-related problems. European Journal of Hospital Pharmacy : 16 Nov 2020. Available from: URL: http:// dx.doi.org/10.1136/ejhpharm-2020-002492
•
Regis T, et al. Safety of High-Dose Unfractionated Heparin for Prophylaxis of Venous Thromboembolism in Hospitalized Obese Patients. Annals of Pharmacotherapy : 1060028020974569, 20 Nov 2020. Available from: URL: http://dx.doi.org/10.1177/1060028020974569
•
Sandoval T, et al. Incident adverse drug reactions and their effect on the length of hospital stay in older inpatients. International Journal of Clinical Pharmacy : 17 Nov 2020. Available from: URL: https://doi.org/10.1007/ s11096-020-01181-3
•
Sarpatwari A, et al. Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) Program. Drug Safety : 18 Nov 2020. Available from: URL: http://dx.doi.org/10.1007/ s40264-020-01017-z
•
Toussi M, et al. Effectiveness of risk minimisation measures for valproate: A cross-sectional survey among physicians in Europe. Pharmacoepidemiology and Drug Safety : 20 Nov 2020. Available from: URL: http:// dx.doi.org/10.1002/pds.5119
Other adverse reaction research. Reactions Weekly 25 Nov 2020
0114-9954/20/1832-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
803519178
Reactions 28 Nov 2020 No. 1832
Data Loading...
